$33.33
0.12%
NYSE, Oct 05, 10:26 am EDT. Market open.
ISIN
BMG3922B1072
Symbol
G

Genpact Limited Target price 2026 - Analyst rating & recommendation

Genpact Limited Classifications & Recommendation

Buy
50%
Hold
45%
Sell
5%

Genpact Limited Price Target

Target Price $40.29
Price $33.29
Potential
Number of Estimates 14
14 Analysts have issued a price target Genpact Limited 2027 . The average Genpact Limited target price is $40.29. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 20 analysts: 10 Analysts recommend Genpact Limited to buy, 9 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Genpact Limited stock has an average upside potential 2027 of . Most analysts recommend the Genpact Limited stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 5.08 5.55
6.56% 9.18%
EBITDA Margin 15.47% 18.79%
1.23% 21.46%
Net Margin 10.88% 12.73%
0.94% 17.05%

16 Analysts have issued a sales forecast Genpact Limited 2026 . The average Genpact Limited sales estimate is

$5.5b
unlock
. This is
5.64% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$5.7b 8.86%
unlock
, the lowest is
$5.3b 1.39%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $5.1b 6.56%
2026
$5.5b 9.18%
unlock
2027
$5.9b 7.10%
unlock
2028
$6.4b 8.15%
unlock

11 Analysts have issued an Genpact Limited EBITDA forecast 2026. The average Genpact Limited EBITDA estimate is

$1.0b
unlock
. This is
30.14% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$1.1b 41.88%
unlock
, the lowest is
$923m 15.26%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $786m 7.87%
2026
$1.0b 32.59%
unlock
2027
$1.1b 8.16%
unlock
2028
$1.3b 11.18%
unlock

EBITDA Margin

2025 15.47% 1.23%
2026
18.79% 21.46%
unlock
2027
18.97% 0.96%
unlock
2028
19.50% 2.79%
unlock

16 Genpact Limited Analysts have issued a net profit forecast 2026. The average Genpact Limited net profit estimate is

$706m
unlock
. This is
21.17% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$730m 25.36%
unlock
, the lowest is
$672m 15.31%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $552m 7.56%
2026
$706m 27.79%
unlock
2027
$774m 9.58%
unlock
2028
$865m 11.84%
unlock

Net Margin

2025 10.88% 0.94%
2026
12.73% 17.05%
unlock
2027
13.02% 2.28%
unlock
2028
13.47% 3.46%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 3.13 4.20
9.82% 34.19%
P/E 7.92
EV/Sales 1.13

16 Analysts have issued a Genpact Limited forecast for earnings per share. The average Genpact Limited EPS is

$4.20
unlock
. This is
23.17% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$4.35 27.57%
unlock
, the lowest is
$4.00 17.30%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $3.13 9.82%
2026
$4.20 34.19%
unlock
2027
$4.60 9.52%
unlock
2028
$5.15 11.96%
unlock

P/E ratio

Current 9.76 29.69%
2026
7.92 18.87%
unlock
2027
7.23 8.71%
unlock
2028
6.46 10.65%
unlock

Based on analysts' sales estimates for 2026, the Genpact Limited stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.19 26.54%
2026
1.13 4.98%
unlock
2027
1.06 6.63%
unlock
2028
0.98 7.54%
unlock

P/S ratio

Current 1.07 28.60%
2026
1.01 5.34%
unlock
2027
0.94 6.63%
unlock
2028
0.87 7.53%
unlock

Current Genpact Limited Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Needham
Locked
➜
Locked
Locked Aug 07 2026
TD Cowen
Locked
➜
Locked
Locked Aug 07 2026
JP Morgan
Locked
➜
Locked
Locked Aug 07 2026
Susquehanna
Locked
➜
Locked
Locked Aug 07 2026
Citigroup
Locked
➜
Locked
Locked Aug 07 2026
TD Cowen
Locked
➜
Locked
Locked Jul 09 2026
Baird
Locked
➜
Locked
Locked Jul 07 2026
Analyst Rating Date
Locked
Needham:
Locked
➜
Locked
Aug 07 2026
Locked
TD Cowen:
Locked
➜
Locked
Aug 07 2026
Locked
JP Morgan:
Locked
➜
Locked
Aug 07 2026
Locked
Susquehanna:
Locked
➜
Locked
Aug 07 2026
Locked
Citigroup:
Locked
➜
Locked
Aug 07 2026
Locked
TD Cowen:
Locked
➜
Locked
Jul 09 2026
Locked
Baird:
Locked
➜
Locked
Jul 07 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today